Validation study of the AGE-Reader device (Trade Mark) in the Brazilian population with or without kidney diseases

Not Applicable

Recruiting

• Conditions: Atherosclerotic cardiovascular disease; End stage renal disease; I25.0; N18.0

• Registration Number: RBR-8sk5j9
• Lead Sponsor: Serviço de Nefrologia do Departamento de Clínica Médica da Faculdade de Ciências Médicas (FCM) da Universidade Estadual de Campinas (UNICAMP),

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-08-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Control group: Will include 300 individuals with age greater than or equal to 18 years; with Fitzpatrick skin phototype I to IV; no history of Diabetes Mellitus and Chronic Renal Disease or smoking.

Chronic Kidney Disease Group (CKD): 300 patients with CKD according to the criteria of Kidney International Disease Improvement Global Outcome (KDIGO) and treated at the HC-FCM-UNICAMP Nephrology Service; 75 of them in stage 3B of CKD, 75 in stage 4 or 5 non-dialytic of CKD, 75 on hemodialysis, and 75 on peritoneal dialysis; with age greater than or equal to 18 years. Patients with DM or smokers will not be excluded.

Exclusion Criteria

Control Group: Individuals aged younger than 18 years; with Fitzpatrick skin type VI to VI; with a history of Diabetes Mellitus and smoking; and individuals who do not agree with the terms set forth in the Free and Informed Consent Term will be excluded.

Chronic Kidney Disease Group: Individuals aged younger than 18 years; with a Fitzpatrick skin V to VI phototype; individuals who do not agree with the terms set forth in the Free and Informed Consent Term will be excluded.

Study & Design

• Study Type: Intervention
• Study Design: Not specified